Download ACS 2013 health insurance [PDF - <1.0 MB] 1  Percent insured with private health insurance: 64.5 percent. This was not statistically different from 65.2 percent in 2010. 2  Uninsured: 18.7 percent. This was down from 19.9 percent in 2010.
This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers.
Femara (letrozole) is a non-steroidal aromatase inhibitor (lowers estrogen production) used to treat breast cancer in postmenopausal women. Femara is often given to women who have been taking tamoxifen (Nolvadex, Soltamox) for 5 years. Femara is available in generic form. Common side effects of Femara include: